CURLFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Curaleaf Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$7.63−0.20 (-2.55%)
Close on Oct 19, 2026
- Market cap
- $2.07B
- P/E (TTM)
- –
- Dividend yield
- –
Curaleaf Holdings, Inc. cash flow statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY2025
- Gross margin
- 49.8%
- Operating margin
- 2.0%
- Net margin
- -18.2%
- Return on equity, FY2025
- -28.6%
Financial strength
- Current ratio
- 1.52
- Debt to equity
- 0.70
- Debt to assets
- 21.7%
- Cash to current liabilities
- 30.8%
Valuation
- P/E ratio
- –
- Price to sales
- 1.63
- Price to book
- 2.38
- Dividend yield
- –